| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 510 |
| 1 | PREDNISOLONE ORAL | 510 |
| 2 | PREDNISOLONE ORAL SOLUTION | 510 |
| 3 | CYCLOPHOSPHAMIDE | 362 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 362 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 362 |
| 6 | METHOTREXATE SODIUM | 352 |
| 7 | INFLIXIMAB | 340 |
| 8 | METHOTREXATE | 337 |
| 9 | RITUXIMAB | 260 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTAMIDINE ISETHIONATE | 24 | 0.0191 |
| 1 | THIOGUANINE | 9 | 0.0042 |
| 2 | RALTEGRAVIR | 21 | 0.0040 |
| 3 | GRANULOCYTE COLONY STIMULATING FACTOR | 8 | 0.0037 |
| 4 | ZIDOVUDINE | 36 | 0.0035 |
| 5 | BLEOMYCIN SULFATE | 33 | 0.0032 |
| 6 | LOPINAVIR AND RITONAVIR | 42 | 0.0031 |
| 7 | TEMSIROLIMUS | 14 | 0.0031 |
| 8 | ABACAVIR SULFATE | 29 | 0.0030 |
| 9 | LAMIVUDINE | 75 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 877 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 493 |
| 2 | Alkylating Drug [EPC] | 425 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 344 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 261 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 178 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 156 |
| 7 | Proton Pump Inhibitor [EPC] | 140 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 131 |
| 9 | Sulfonamide Antimicrobial [EPC] | 123 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 7 | 0.0070 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 50 | 0.0021 |
| 2 | Protease Inhibitor [EPC] | 87 | 0.0020 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 86 | 0.0017 |
| 4 | Alkylating Drug [EPC] | 425 | 0.0017 |
| 5 | Antimycobacterial [EPC] | 40 | 0.0016 |
| 6 | CD33-directed Immunoconjugate [EPC] | 6 | 0.0016 |
| 7 | Antimalarial [EPC] | 17 | 0.0016 |
| 8 | Antiprotozoal [EPC] | 17 | 0.0016 |
| 9 | Topoisomerase Inhibitor [EPC] | 122 | 0.0016 |